false
OasisLMS
Catalog
SCCM Resource Library
Resuscitating the Letter C: Choice of Analgesia an ...
Resuscitating the Letter C: Choice of Analgesia and Sedation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the speaker discusses the best practices for managing analgesics and sedatives in the ICU. They emphasize the importance of routine assessment of sedation levels and using the widest level of sedation possible. They also highlight the negative effects of deep sedation, such as prolonged intubation and increased risk. The use of non-benzodiazepine sedatives like propofol and dexmedetomidine is recommended over benzodiazepines like midazolam. The speaker also discusses the impact of the COVID-19 pandemic on sedation practices, noting that there was a regression in the use of light sedation and non-benzodiazepine sedatives during the pandemic. They stress the need for re-education and the use of strategies like restarting pre-hospital medications, clustering patient activity, and involving clinical pharmacists to optimize sedation practices. In conclusion, choosing the right analgesic and sedative is crucial for providing the best ICU care, and it is important not to regress in sedation practices post-COVID-19.
Asset Subtitle
Quality and Patient Safety, Pharmacology, 2023
Asset Caption
Type: two-hour concurrent | Resuscitating the ICU Liberation Bundle Following COVID-19 (SessionID 9990088)
Meta Tag
Content Type
Presentation
Knowledge Area
Quality and Patient Safety
Knowledge Area
Pharmacology
Learning Pathway
Delirium and Sedation Managment
Membership Level
Professional
Membership Level
Select
Tag
Guidelines
Tag
Analgesia and Sedation
Year
2023
Keywords
ICU management
sedation levels
non-benzodiazepine sedatives
COVID-19 pandemic
sedation practices
×
Please select your language
1
English